Combination Seasonal Vaccines for Influenza, Respiratory Syncytial Virus, Severe Acute Respiratory Syndrome Coronavirus 2, and Other Pathogens - Top-Institutions - MDSpire

Combination Seasonal Vaccines for Influenza, Respiratory Syncytial Virus, Severe Acute Respiratory Syndrome Coronavirus 2, and Other Pathogens

  • By

  • David Dobrzynski

  • Angela R Branche

  • Ann R Falsey

  • October 15, 2024

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Vaccine Research
    • Immunology

  • #2

    Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), NIH
    Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), NIH

    Bethesda, MD

    Key Differentiators

    • Vaccine Development
    • Virology
    • Immunology

  • #3

    University of Oxford
    University of Oxford

    Oxford, United Kingdom

    Key Differentiators

    • Vaccine Development
    • Infectious Diseases
    • Clinical Trials

  • #4

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Epidemiology
    • Vaccine Policy
    • Public Health

  • #5

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Immunology
    • Vaccine Research
    • Infectious Diseases

Original Source(s)

Combination Seasonal Vaccines for Influenza, Respiratory Syncytial Virus, Severe Acute Respiratory Syndrome Coronavirus 2, and Other Pathogens

  • by David Dobrzynski, Angela R Branche, Ann R Falsey

  • October 15, 2024

Related Content

Assessing PEPFAR’s Health Spillover Effects Beyond HIV: An Update

Stewardship Cuts Steroid Prescribing

Behaviorally informed peer comparison feedback was associated with a gradual decline in glucocorticoid prescribing

Clinical characteristics and antibody responses to Omicron variants among pregnant women in China during the December 2022–April 2023 COVID-19 pandemic wave